Figure 3.

Bioassay in LT mice using androgen-responsive tissue weight after ORX and with DHT treatment. A. SV weight during LT intervention as a therapeutic treatment for established bone loss. (n = 5–26). B. LABC muscle weight during HT. (n = 3–12). All data expressed as mean ± SEM. Significance was assessed by one-way ANOVA with Newman-Keuls Multiple Comparison post-hoc test or two-sided student's t-test. *** p < 0.001 vs. sham controls; ^### p < 0.001 vs. ORX.